首页> 美国卫生研究院文献>Interventional Cardiology Review >‘Primary’ Microvascular Angina: Clinical Characteristics Pathogenesis and Management
【2h】

‘Primary’ Microvascular Angina: Clinical Characteristics Pathogenesis and Management

机译:原发性微血管性心绞痛:临床特征发病机制和治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microvascular angina (MVA), i.e. angina caused by abnormalities of the coronary microcirculation, is increasingly recognised in clinical practice. The pathogenetic mechanisms of MVA are heterogeneous and may involve both structural and functional alterations of coronary microcirculation, and functional abnormalities may variably involve an impairment of coronary microvascular dilatation and an increased microvascular constrictor activity. Both invasive and non-invasive diagnostic tools exist to identify patients with MVA in clinical practice. Prognosis has been reported to be good in primary MVA patients, although the prognostic implications of coronary microvascular dysfunction (CMVD) in more heterogeneous populations of angina patients need further assessment. Management of primary MVA can be challenging, but pharmacological and non-pharmacological treatments exist that allow satisfactory control of symptoms in most patients.
机译:微血管心绞痛(MVA),即由冠状动脉微循环异常引起的心绞痛,在临床实践中得到越来越多的认可。 MVA的致病机制是异质的,可能涉及冠状动脉微循环的结构和功能改变,而功能异常可能可变地涉及冠状动脉微血管扩张障碍和微血管收缩活动增加。侵入性和非侵入性诊断工具都可以在临床实践中识别出MVA患者。据报道,原发性MVA患者的预后良好,尽管冠心病患者的异质性人群中冠状动脉微血管功能障碍(CMVD)的预后需要进一步评估。原发性MVA的治疗可能具有挑战性,但是存在药理学和非药理学治疗方法,可以使大多数患者满意地控制症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号